Skip to content

Agios Pharmaceuticals

US · AGIO #2841 by market cap Listed 1970
27.60 -1.16 -4.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/11/6
  • Rating change
    Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
    Market Newswire · 2026/8/11
  • Rating change
    Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39
    Market Newswire · 2026/7/31
  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $54
    Market Newswire · 2026/7/13
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $35
    Market Newswire · 2026/11/6
  • Rating change
    A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $39 to $55
    Market Newswire · 2026/7/31
  • Rating change
    H.C. Wainwright Initiates Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $55
    Market Newswire · 2026/10/29
  • H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $62
    Market Newswire · 2026/11/6
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/7/22
  • Rating change
    Citi Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $52
    Market Newswire · 2026/10/28
  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $52
    Market Newswire · 2026/7/22
  • BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $48
    Market Newswire · 2026/11/6
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/9/21
  • Company notice
    Agios Pharmaceuticals: Agios Pharmaceuticals, Inc. - Flex Position Consolidation Option Symbol: 1AGIO
    OCC · 2022/4/28
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/11/6
  • Rating change
    RBC Capital Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Raises Target Price to $32
    Market Newswire · 2026/10/9
  • Rating change
    TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
    Market Newswire · 2026/8/4
  • RBC Capital Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Maintains Target Price $32
    Market Newswire · 2026/11/6
  • Rating change
    Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $37
    Market Newswire · 2026/10/7
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/10/6
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/7/7
  • Rating change
    A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $36 to $54
    Market Newswire · 2026/6/16
  • Rating change
    A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $41 to $54
    Market Newswire · 2026/7/8
  • Rating change
    H.C. Wainwright Remains a Buy on Agios Pharma (AGIO)
    TipRanks · 2026/7/13
  • H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/10/30

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Agios Pharmaceuticals discussion 0 comments

Add a comment